期刊文献+

P53突变蛋白在膀胱癌及癌旁组织中的表达 被引量:4

Expression of mutant P53 gene in bladder carcinoma and adjacent bladder mucosa
原文传递
导出
摘要 应用ABC免疫组化方法及核仁组成区(NORs)染色对55例手术切除的膀胱癌及癌旁膀胱粘膜组织石蜡包埋标本进行了P53突变蛋白表达的检测及AgNOR颗粒计数。结果:55例膀胱癌标本中33例P53突变蛋白高表达,阳性率为60.0%;55例癌旁粘膜中13例P53蛋白弱表达。伴有盆腔淋巴结转移的23例膀胱癌标本中20例(87.0%)P53蛋白高表达,11例癌旁组织弱表达。P53表达阳性的膀胱癌组织中,每核AgNOR颗粒平均数(9.51±1.87)较P53表达阴性者(6.71±1.68)明显增多(P<0.01)。结果提示:抑癌基因P53的突变是肿瘤增生异常活跃的因素之一,在膀胱癌的发生中是一种比较常见的基因突变,与膀胱癌的浸润和转移能力密切相关。 With ABC immunohistochemical technique,the expression of P53 was studied in paraffin sections of the tumor tissue and the adjacent mucosa resected from 55 patients with bladder cancer.P53 was found to be positive in the nuclei with extensive staining in 33(60.0%),the P53 positive cells being distributed diffusedly in the cancer tissue. 23 adjacent mucosa specimens were weakly stained.In cancer patients with metaplasia in the pelvic lymph nodes,P53 was positive in 20 tumor specimens out of 23(87.0%).AgNORs was also studied with silver staining technique.The number of AgNOR dots per nucleus detected in bladder cancer sections with positive p53staining(9.5±2.87) was greater than those with negative staining(6.7±1.68).The difference was statistically significant(P<0.01).The result suggested that P53 mutation might be one of the genetic events in the development of bladder cancer and might play an important role in tumor invasion and metastasis.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 1995年第12期725-726,共2页 Chinese Journal of Urology
关键词 膀胱肿瘤 核仁组成区 免疫组织化学 Bladder neoplasms Nucleouls organizer regions Immunohistochemistry
  • 相关文献

参考文献1

  • 1周兴,中华泌尿外科杂志,1992年,13卷,272页

同被引文献10

  • 1马文香,王乃宁.膀胱癌生物学特性的研究:26例膀胱全切除术标本组织图分析[J].中华泌尿外科杂志,1989,10(4):217-220. 被引量:3
  • 2吴长利,马腾骧.多药耐药基因与膀胱癌[J].中华泌尿外科杂志,1996,17(4):251-253. 被引量:2
  • 3Patrick CW,Alan BR,Thomas AS,et al.Campell′s Urology:sixth edition[M].U.S.A:W.B.Saunders Company Harcourt Brace Jovanovich Inc.1992:2767.
  • 4Thomas DJ,Robinson MC,Charlton R,et al.p53 expression ploidy and progression in PT1 transitional cell carcinoma of bladder[J].Br J Urol,1994,73(5):533.
  • 5Plastiras D,Moutzouris G,Barbatis C,et al.Can p53 nuclear over-expression,bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superfical and invasive bladder tumor?[J].Eur J Surg Oncol,1999,25(1):613.
  • 6Lu QL,Laninado M,Abel PD,et al.Expression of bcl-2 in bladder neoplasms is a cell lineage associated and p53-in-depent event[J].J Clin Path,1997,50(1):28.
  • 7Shiina H,Igawa M,Urakami S,et al.Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder[J].J Clin Pathol,1996,49(5):395.
  • 8Igawa M.Studies on multiple mucosal biopsy in patients with bladder cancer.Evaluation of the results of multiple methylene blue staining[J].Hinyokika kiyo,1986,32(11):1617.
  • 9Rao JY,Hemstreet GP,Hurst RE,et al.Alternations in phenotypic biochemical maker in bladder epithelium during tumorgenesis[J].Proc Acad Sci U.S.A,1993,90(17):8287.
  • 10周兴.细胞周期调控基因-P21WAF1/CIP1及抑癌基因失活与膀胱癌的关系[J].国外医学(泌尿系统分册),1998,18(5):217-219. 被引量:1

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部